Arthur F Ryan Insider Trading Activity
Every SEC Form 4 transaction reported by Arthur F Ryan, sourced directly from SEC EDGAR and updated as new filings are accepted.
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Arthur F Ryan buying or selling?
Arthur F Ryan reported 0 open-market buys ($0) and 53 sells ($37.9M) across 53 Form 4 filings at 1 company — a net selling position of $37.9M.
Source: SEC EDGAR Form 4
What stands out
- All 53 of Arthur F Ryan's Form 4 filings are for one company, REGENERON PHARMACEUTICALS, INC. (REGN).
- The most recent Form 4 was accepted on Jul 7, 2026 (3 months ago).
- In the last 12 months: no open-market purchases and 5 sales ($434.7K).
- The largest open-market sale in the last 12 months was $130.0K of REGENERON PHARMACEUTICALS, INC. (REGN) on Jul 7, 2026. SEC ↗
Key Statistics (as of Jul 7, 2026)
Insider sentiment
Net sellingNet insider flow of $37.9M in net selling, filed between Apr 1, 2020 – Jul 7, 2026.
Companies Arthur F Ryan files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | REGNREGENERON PHARMACEUTICALS, INC. | 53 |
Recent Arthur F Ryan transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | REGN | Director | Sale | 200 | $130.0K | SEC ↗ |
| May 4, 2026 | REGN | Director | Sale | 100 | $70.5K | SEC ↗ |
| Apr 3, 2026 | REGN | Director | Sale | 100 | $77.7K | SEC ↗ |
| Mar 3, 2026 | REGN | Director | Sale | 100 | $78.5K | SEC ↗ |
| Feb 11, 2026 | REGN | Director | Sale | 100 | $77.9K | SEC ↗ |
| Oct 3, 2024 | REGN | Director | Sale | 100 | $104.9K | SEC ↗ |
| Sep 5, 2024 | REGN | Director | Sale | 100 | $117.9K | SEC ↗ |
| Aug 5, 2024 | REGN | Director | Sale | 1 | $1.1K | SEC ↗ |
| Aug 5, 2024 | REGN | Director | Sale | 99 | $107.5K | SEC ↗ |
| Jul 2, 2024 | REGN | Director | Sale | 100 | $105.9K | SEC ↗ |
| Jun 5, 2024 | REGN | Director | Sale | 100 | $99.4K | SEC ↗ |
| May 3, 2024 | REGN | Director | Sale | 100 | $90.0K | SEC ↗ |
| Apr 3, 2024 | REGN | Director | Sale | 100 | $96.3K | SEC ↗ |
| Mar 5, 2024 | REGN | Director | Sale | 100 | $98.2K | SEC ↗ |
| Feb 5, 2024 | REGN | Director | Sale | 100 | $95.4K | SEC ↗ |
| Jan 4, 2024 | REGN | Director | Sale | 100 | $90.0K | SEC ↗ |
| Dec 4, 2023 | REGN | Director | Sale | 100 | $81.7K | SEC ↗ |
| Nov 8, 2023 | REGN | Director | Sale | 100 | $82.8K | SEC ↗ |
| Aug 3, 2023 | REGN | Director | Sale | 100 | $73.7K | SEC ↗ |
| Jul 6, 2023 | REGN | Director | Sale | 100 | $71.7K | SEC ↗ |
| Jun 2, 2023 | REGN | Director | Sale | 100 | $73.5K | SEC ↗ |
| May 3, 2023 | REGN | Director | Sale | 100 | $80.5K | SEC ↗ |
| Apr 5, 2023 | REGN | Director | Sale | 100 | $81.9K | SEC ↗ |
| Mar 3, 2023 | REGN | Director | Sale | 100 | $76.2K | SEC ↗ |
| Feb 3, 2023 | REGN | Director | Sale | 100 | $75.6K | SEC ↗ |
Showing the 25 most recent filings of 53. Screen every filing.
Arthur F Ryan insider trading FAQ
Is Arthur F Ryan buying or selling?
Across 53 SEC Form 4 filings, Arthur F Ryan reported 0 open-market purchases totaling $0 and 53 sales totaling $37.9M — a net selling position of $37.9M.
Which companies does Arthur F Ryan file Form 4s for?
Arthur F Ryan has reported insider transactions at 1 company, most often REGENERON PHARMACEUTICALS, INC. (REGN).
How far back does Arthur F Ryan's filing history go?
Trabud holds Arthur F Ryan's SEC Form 4 filings from Apr 1, 2020 – Jul 7, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Arthur F Ryan's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Arthur F Ryan and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener